JPWO2022080249A1 - - Google Patents

Info

Publication number
JPWO2022080249A1
JPWO2022080249A1 JP2022556908A JP2022556908A JPWO2022080249A1 JP WO2022080249 A1 JPWO2022080249 A1 JP WO2022080249A1 JP 2022556908 A JP2022556908 A JP 2022556908A JP 2022556908 A JP2022556908 A JP 2022556908A JP WO2022080249 A1 JPWO2022080249 A1 JP WO2022080249A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022556908A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022080249A1 publication Critical patent/JPWO2022080249A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2022556908A 2020-10-12 2021-10-08 Pending JPWO2022080249A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020171646 2020-10-12
PCT/JP2021/037311 WO2022080249A1 (en) 2020-10-12 2021-10-08 Agent for preventing or ameliorating inflammatory bowel disease

Publications (1)

Publication Number Publication Date
JPWO2022080249A1 true JPWO2022080249A1 (en) 2022-04-21

Family

ID=81208102

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022556908A Pending JPWO2022080249A1 (en) 2020-10-12 2021-10-08

Country Status (2)

Country Link
JP (1) JPWO2022080249A1 (en)
WO (1) WO2022080249A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4378088B2 (en) * 2002-02-22 2009-12-02 日本臓器製薬株式会社 Piperazine derivatives
CA2698754A1 (en) * 2007-09-11 2009-03-19 Dorian Bevec Use of a peptide as a therapeutic agent
JP2012214451A (en) * 2011-03-25 2012-11-08 En Otsuka Pharmaceutical Co Ltd Amino acid composition for inflammatory disease
US20210283082A1 (en) * 2018-06-07 2021-09-16 National University Corporation Kanazawa University Pharmaceutical composition for prevention or treatment of kidney damage
JP7467138B2 (en) * 2020-01-30 2024-04-15 株式会社 資生堂 Intestinal barrier improver
WO2021167032A1 (en) * 2020-02-18 2021-08-26 学校法人慶應義塾 Drug and food for treating and/or preventing enteritis and/or hepatitis

Also Published As

Publication number Publication date
WO2022080249A1 (en) 2022-04-21

Similar Documents

Publication Publication Date Title
BR112023005462A2 (en)
BR112021014123A2 (en)
BR112023012656A2 (en)
BR112022009896A2 (en)
JPWO2021167032A1 (en)
BR112022024743A2 (en)
BR112023009656A2 (en)
BR102021018859A2 (en)
BR102021015500A2 (en)
BR112023011738A2 (en)
BR112023016292A2 (en)
BR112023004146A2 (en)
BR112023011610A2 (en)
BR112023011539A2 (en)
BR112023008976A2 (en)
BR112023006729A2 (en)
JPWO2022080249A1 (en)
BR102021020147A2 (en)
BR102021018926A2 (en)
BR102021018167A2 (en)
BR102021017576A2 (en)
BR102021016837A2 (en)
BR102021016551A2 (en)
BR102021016375A2 (en)
BR102021016200A2 (en)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230412